Rohto Pharmaceutical Co., Ltd.: Business Overview, Financials & Competitive Analysis
Rohto Pharmaceutical Co., Ltd. scores 6/10 on the AskCyborg Cyborg Score (Solid). Established market leader with stable margins trading at a valuation premium to growth expectations, appealing to dividend-focused investors despite below-market growth forecasts. Rohto is currently running a trailing net profit margin of 10.3%, compared with 10.0% a year earlier, while revenue growth is forecast at about 4.5% per.
What is Rohto Pharmaceutical Co., Ltd.'s industry? Rohto Pharmaceutical Co., Ltd. (rohto.co.jp) operates in Household & Personal Products / Over-The-Counter Pharmaceuticals. AskCyborg classifies Rohto Pharmaceutical Co., Ltd. under Household & Personal Products / Over-The-Counter Pharmaceuticals in its company registry.
Rohto Pharmaceutical manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. ROHTO Pharmaceutical Co. is the largest company in Japan's OTC drugs market, commanding a 40% share in ...
Cyborg Score thesis
Established market leader with stable margins trading at a valuation premium to growth expectations, appealing to...
Read the full analyst-debate transcript →Get the Latest Rohto Pharmaceutical Co., Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeRohto Pharmaceutical Co., Ltd. Overview
Pro stress-test →Rohto Pharmaceutical manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. ROHTO Pharmaceutical Co. is the largest company in Japan's OTC drugs market, commanding a 40% share in the eye-drop sector. The company has demonstrated strong historical growth and maintains a diversified portfolio of consumer health and beauty products.
Strategic Profile
Pro stress-test →Rohto is a leading Japanese pharmaceutical company based in Osaka, Japan that operates primarily in the healthcare and wellness industry, specializing in over-the-counter drugs, skin care products, and functional foods. The company operates beauty counters that provide beauty and health services, manufactures and sells diagnostic reagents, and provides investment management services and contract development and manufacturing services.
Competitive Landscape
Pro stress-test →Rohto Pharmaceutical is the largest company in Japan's OTC drugs market, commanding a 40% share in the eye-drop sector. The company competes with multinational pharmaceutical and consumer healthcare companies in Japan and globally, while maintaining dominant market share in specific therapeutic categories.
Industry Context
Rohto Pharmaceutical Co., Ltd. operates in Household & Personal Products / Over-The-Counter Pharmaceuticals.
Key facts
Founded: 1899 · Headquarters: Osaka, Japan · Employees: 9,144 · Revenue: ~¥328B (annualized from interim data) · Market cap: ¥555.6B